XPH SPDR S&P Pharmaceuticals ETF

*Unless otherwise stated, data provided by FactSet.

What is XPH?

XPH tracks an equal-weighted index of US pharmaceutical companies.

XPH Factset Analytics Insight

XPH offers equal-weighted exposure to a narrow selection of US pharmaceutical companies, stretching across all market caps. XPH's weighting scheme causes it to be far less concentrated than the industry, which is dominated by a handful of mega-cap names like J&J, Pfizer and Merck. The fund also introduces a heavy tilt to mid- and small-caps, which makes for a rather volatile fund relative to the industry. Overall, XPH is a solid way to capture a less concentrated version of the pharma market. The index is rebalanced quarterly.

PERFORMANCE [as of 03/20/23] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
XPH -5.18% 0.85% 0.31% -8.44% 9.82% 0.29% 4.79%
XPH (NAV) -5.12% 0.93% 0.31% -8.31% 9.88% 0.31% 4.80%
S&P Pharmaceuticals Select Industry -5.13% 0.92% 0.30% -8.75% 9.83% 0.31% 4.88%
MSCI USA IMI / Pharmaceuticals -IND -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

XPH Summary Data

SPDR
06/19/06
Open-Ended Fund
0.35%
$193.08M
$2.12M
0.11%

XPH Portfolio Data

$62.03B
1,966.00
3.14
1.48%
N/A
42

XPH Index Data

S&P Pharmaceuticals Select Industry
Equal
Market Cap
MSCI USA IMI / Pharmaceuticals -IND

XPH Portfolio Management

0.35%
0.31%
0.57%
-0.03%

XPH Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

XPH Fund Structure

Open-Ended Fund
No
Yes
-- / --
N/A
N/A
Low
Daily

XPH Factset Analytics Block Liquidity

As of 03/21/23
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of XPH. XPH is rated a 5 out of 5.

XPH Tradability

50,269
$2.12M
24,843
$1.05M
0.11%
$0.05
-0.01%
0.16% / -0.16%
None
100.00%
50,000
0.50
0.01%
0.14%
321
$40.99
5

XPH Sector/Industry Breakdown


XPH
Segment Benchmark
99.60%
--
0.40%
--

XPH Countries


XPH
Segment Benchmark
99.84%
--

XPH Regions


XPH
Segment Benchmark
99.84%
--

XPH Economic Development


XPH
Segment Benchmark
99.84%
--
0.00%
--

XPH Performance Statistics

--
--
--
--
--
MSCI USA IMI / Pharmaceuticals -IND

XPH Benchmark Comparison Holdings

42
--
--
--

XPH Benchmark Comparison Summary


XPH
Segment Benchmark
42
--
$62.03B
--
1,966.00
--
3.14
--
1.06%
--
Medium
--

XPH Benchmark Comparison Market Cap Size


XPH
Segment Benchmark
31.76%
--
38.99%
--
26.00%
--
3.09%
--